Metoprolol Succinate Extended-Release Tablets 25 mg
Ascend Laboratories is recalling 25 mg Metoprolol Succinate Extended-Release Tablets due to failed dissolution testing.
Contact your healthcare provider or pharmacist to discuss alternative treatment options. Do not stop taking this medication without consulting your doctor.
Why it was recalled
Ascend Laboratories is recalling Metoprolol Succinate Extended-Release Tablets, 25 mg, due to failed dissolution testing. This medication is used to treat high blood pressure and chest pain.
Is mine affected?
Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.
Ascend Laboratories, LLC, Metoprolol Succinate Extended-Release Tablets, USP, 25 mg* Rx Only, Manufactured by: Alkem Laboratories Ltd., India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-590-01.
- UPC
- 25140859
- Recall #
- D-0547-2026
Where it was sold
Distributed nationwide.
Official source
Other recent recalls from Ascend Laboratories, LLC
Editorial summary by Recall Canary · last updated 2026-05-21 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification